BNET Industries

Raptor Pharmaceuticals Corp.

(RPTP) is in the Pharma Industry

Market Cap:$66.2M
  • Public
  • US
Dow Jones Description

This annual report contains forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. These statements relate to future events or our future financial performance. In some cases, you can identify forward-looking statements by terminology such as "may", "should", "expects", "plans", "anticipates", "believes", "estimates", "predicts", "potential" or "continue" or the negative of these terms or other comparable terminology. These statements are only predictions and involve known and unknown risks, uncertainties and other factors, including the risks in the section entitled "Risk Factors", that may cause our or our industry's actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements. Except as required by applicable law, including the securities laws of the United States, we do not intend to update any of the forward-looking statements to conform these statements to actual results.

Contact Information

9 Commercial Blvd, Suite 200

Novato, California 94949

415-382-1390

NAICS Code Pharmaceutical Preparation Manufacturing: 325412

Recent Events

  • Raptor reports results from two programs

    11/24/09 - Merger / Acquisition - View Story

  • Raptor Pharmaceutical Corp. to Present at the 8th Annual BIO Investor Forum

    10/27/09 - Merger / Acquisition - View Story

  • Raptor Pharmaceutical expands board

    10/01/09 - Merger / Acquisition - View Story

  • Raptor Pharmaceuticals Corp. and TorreyPines Complete Merger

    10/04/09 - Merger / Acquisition - View Story

  • Vista Partners Updates Coverage on Raptor Pharmaceuticals Corp. (OTCBB: RPTP); Raises...

    9/02/09 - Bond / Stock Rating - View Story

  • Raptor Pharmaceuticals Schedules 2009 Annual Meeting of Stockholders

    8/31/09 - Joint Venture / Alliance - View Story

  • Raptor Pharmaceuticals to merge with TorreyPines

    7/28/09 - Merger / Acquisition - View Story

  • Company, People, and Regulatory Briefs: Amgen and GSK Collaborate; WuXi Appoints VP of Pharmacology; More...

    7/29/09 - Merger / Acquisition - View Story

News & Analysis

raptor pharmaceuticals corp. - All News and Analysis

advertisement
     RPTP $3.52 +0.14 (4.14% )
Intraday | 3 Month | 6 Month | 1 Year
Average Volume 56,157
Shares Outstanding 940.75K
Market Cap 3.3M
Year High 4
Year Low 0.101
Earnings Per Share -15.30
P/E Ratio -0.23
Dividend N/A
Yield N/A
IndustryTop Rated
advertisement
Click Here